AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

This is especially true for older adults with type 2 diabetes (T2D) taking insulin and/or sulfonylureas — steadfast older ...

The LENNY trial highlighted the system's efficacy and safety in children aged two to six years with type 1 diabetes.